Schistosome and Intestinal Worm Infections and Malaria Morbidity Among School and Pre-School Children in, Tanzania
Information source: DBL -Institute for Health Research and Development
Information obtained from ClinicalTrials.gov on June 20, 2008 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Anaemia; Malaria; Hepatosplenomegaly
Intervention: Albendazole and praziquantel (Drug)
Phase: N/A
Status: Active, not recruiting
Sponsored by: DBL -Institute for Health Research and Development Official(s) and/or principal investigator(s): Safari M Kinung'hi, Msc, Principal Investigator, Affiliation: National Insitute for Medical Research, Mwanza, Tanzania
Summary
The proposed study has as the main objective to investigate the effect of schistosome and STH
infections and the effect of an anthelminthic intervention on P. falciparum malaria, related
anaemia and malaria antibody responses among school and pre-school children in Mwanza,
Tanzania. The study will include a cross-sectional baseline survey followed by an
anthelminthic intervention trial of two years duration. At baseline, prevalence and intensity
of malaria, schistosome and STH infections and the prevalence of anaemia will be determined
by examination of blood, faecal and urine samples. Spleen and liver size and consistency will
be determined by palpation. P. falciparum specific antibodies will be determined by ELISA.
All children will be treated with a single dose of praziquantel 40mg/kg and albendazole
400mg. Children selected to participate in the intervention trial will be randomized into two
groups, an intervention group of 258 children which will be followed up with albendazole
400mg and praziquantel 40mg/kg at three months interval and a control group of 258 children
which will be followed up with praziquantel 40mg/kg and albendazole 400mg once a year in
accordance with the National Schistosomiasis and Soil-transmitted Helminths Control
Programme. At 12 months and 24 months follow-up, all examinations conducted at baseline
survey will be repeated.
Clinical Details
Official title: The Effect of Schistosome and Soil-Transmitted Helminth Infections on Malaria,Infection, Morbidity and Antibody Response Among School and Pre-School Children in Mwanza, Tanzania
Study design: Prevention, Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study
Primary outcome: incidence of malaria casesSpleen and liver size Hæmoglobin P. falciparum specific antibodies (IgG3) Prevalence and intensity of schistosome anfd intestinal helminth infections
Detailed description:
alaria is a major public health problem in tropical and subtropical countries particularly
sub-Saharan Africa. Studies have shown that in Tanzania malaria, schistosome and
soil-transmitted helminth infections (STH) (Hookworms, Ascaris lumbricoides and Trichuris
trichiura) are co-endemic and that they share the human hosts. It has been hypothesized that
co-infection with schistosomes and STH may modulate the immune response to Plasmodium
falciparum leading to increased susceptibility to clinical malaria and severity of cases. The
proposed study has as the main objective to investigate the effect of schistosome and STH
infections and the effect of an anthelminthic intervention on P. falciparum malaria, related
anaemia and malaria antibody responses among school and pre-school children in Mwanza,
Tanzania. The study will include a cross-sectional baseline survey followed by an
anthelminthic intervention trial of two years duration. At baseline, prevalence and intensity
of malaria, schistosome and STH infections and the prevalence of anaemia will be determined
by examination of blood, faecal and urine samples. Spleen and liver size and consistency will
be determined by palpation. P. falciparum specific antibodies will be determined by ELISA.
All children will be treated with a single dose of praziquantel 40mg/kg and albendazole
400mg. Children selected to participate in the intervention trial will be randomized into two
groups, an intervention group of 258 children which will be followed up with albendazole
400mg and praziquantel 40mg/kg at three months interval and a control group of 258 children
which will be followed up with praziquantel 40mg/kg and albendazole 400mg once a year in
accordance with the National Schistosomiasis and Soil-transmitted Helminths Control
Programme. At 12 months and 24 months follow-up, all examinations conducted at baseline
survey will be repeated. If an effect of schistosome and STH infections on malaria infection
and morbidity is demonstrated, control of these diseases could provide another feasible and
affordable way of reducing malaria morbidity. Results of the proposed study will contribute
to the understanding of the epidemiology and control of malaria in the context of other
co-endemic diseases and may be important in the planning of integrated disease control
strategies.
Keywords: P. falciparum, malaria, schistosome infections, soil-transmitted helminths
infection, anaemia, immune response, Tanzania
Eligibility
Minimum age: 5 Years.
Maximum age: 15 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- preschool children (>5 years of age) school children standard I-V (>7 years of age
Exclusion Criteria:
- Children with severe malaria or anaemia Children who have receuived anthelmintic
treatment (< 6 months ago)
Locations and Contacts
Mwanza Medical Research Centre, Mwanza, Mwanza Region PO. Box 1462, Tanzania
Additional Information
Starting date: July 2006
Ending date: November 2008
Last updated: April 7, 2008
|